Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Carbapenem-resistant Acinetobacter baumannii (CRAB) is a critical pathogen with limited treatment options.
• Antibiotic resistance in CRAB necessitates novel therapeutic strategies.
• Drug repurposing presents a viable approach for developing new CRAB treatments.

Purpose of the Study:

• To critically evaluate repurposed drugs for CRAB infections.
• To correlate antimicrobial activity with toxicity and side effect data.
• To identify promising drug candidates for CRAB treatment.

Main Methods:

• Literature review of repurposed drugs against CRAB.
• Analysis of antimicrobial efficacy data.
• Assessment of drug toxicity and plasma concentration data.

Main Results:

• Several repurposed drugs show potential but face challenges with toxicity and low plasma concentrations.
• Fusidic acid and colistin demonstrate favorable applicability for CRAB treatment.
• Combination therapy with fusidic acid and colistin may offer improved outcomes.

Conclusions:

• Fusidic acid and colistin are promising candidates for repurposing against CRAB infections.
• Optimizing drug combinations and formulations is crucial for clinical success.
• Further research is needed to fully establish the safety and efficacy of repurposed drugs.